SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-18-000109
Filing Date
2018-08-14
Accepted
2018-08-14 07:38:38
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-063018x10q.htm 10-Q 627649
2 EXHIBIT 31.1 ebio-063018x311.htm EX-31.1 12086
3 EXHIBIT 31.2 ebio-063018x312.htm EX-31.2 11916
4 EXHIBIT 32.1 ebio-063018x321.htm EX-32.1 7005
  Complete submission text file 0001485003-18-000109.txt   3337697

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20180630.xml EX-101.INS 611165
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20180630.xsd EX-101.SCH 27758
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20180630_cal.xml EX-101.CAL 48446
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20180630_def.xml EX-101.DEF 127846
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20180630_lab.xml EX-101.LAB 394412
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20180630_pre.xml EX-101.PRE 228194
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 181014279
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1